Successful azacitidine based treatment of therapy related myelodysplastic syndrome with normal karyotype occurred after acute myeloid leukemia

被引：0
|
作者：
Saltarelli, F. [1 ]
Tatarelli, C. [1 ]
Spiriti, M. A. Aloe [1 ]
Naso, V. [1 ]
Bianchi, M. P. [1 ]
Bianchi, M. P. [1 ]
Conte, E. [1 ]
Proia, S. [1 ]
Ferrari, A. [1 ]
机构：
[1] Univ Roma La Sapienza, S Andrea Hosp, Hematol, I-00185 Rome, Italy
来源：
LEUKEMIA RESEARCH | 2013年 / 37卷
关键词：
D O I：
10.1016/S0145-2126(13)70241-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-194
引用
收藏
页码：S110 / S111
页数：2
相关论文
共 50 条
  • [31] Azacitidine treatment for patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 3q abnormalities
    Wanquet, Anne
    Prebet, Thomas
    Berthon, Celine
    Sebert, Marie
    Roux, Clemence
    Kulasekararaj, Austin
    Micol, Jean-Baptiste
    Esterni, Benjamin
    Itzykson, Raphael
    Thepot, Sylvain
    Recher, Christian
    Delaunay, Jacques
    Dreyfus, Francois
    Mufti, Ghulam
    Fenaux, Pierre
    Vey, Norbert
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (10) : 859 - 863
  • [32] Therapy-related acute myeloid leukemia and myelodysplastic syndrome after hematopoietic cell transplantation for lymphoma
    S Yamasaki
    R Suzuki
    K Hatano
    K Fukushima
    H Iida
    S Morishima
    Y Suehiro
    T Fukuda
    N Uchida
    H Uchiyama
    H Ikeda
    A Yokota
    K Tsukasaki
    H Yamaguchi
    J Kuroda
    H Nakamae
    Y Adachi
    K-i Matsuoka
    Y Nakamura
    Y Atsuta
    J Suzumiya
    Bone Marrow Transplantation, 2017, 52 : 969 - 976
  • [33] Single-center pediatric experience with venetoclax and azacitidine as treatment for myelodysplastic syndrome and acute myeloid leukemia
    Winters, Amanda C.
    Maloney, Kelly W.
    Treece, Amy L.
    Gore, Lia
    Franklin, Anna K.
    PEDIATRIC BLOOD & CANCER, 2020, 67 (10)
  • [34] Therapy-related acute myeloid leukemia and myelodysplastic syndrome after hematopoietic cell transplantation for lymphoma
    Yamasaki, S.
    Suzuki, R.
    Hatano, K.
    Fukushima, K.
    Iida, H.
    Morishima, S.
    Suehiro, Y.
    Fukuda, T.
    Uchida, N.
    Uchiyama, H.
    Ikeda, H.
    Yokota, A.
    Tsukasaki, K.
    Yamaguchi, H.
    Kuroda, J.
    Nakamae, H.
    Adachi, Y.
    Matsuoka, K-I
    Nakamura, Y.
    Atsuta, Y.
    Suzumiya, J.
    BONE MARROW TRANSPLANTATION, 2017, 52 (07) : 969 - 976
  • [35] Treatment of acute myeloid leukemia with antecedent myelodysplastic syndrome
    Larson, RA
    LEUKEMIA, 1996, 10 : S23 - S25
  • [36] Myelodysplastic syndrome and acute myeloid leukemia after treatment with fludarabine, mitoxantrone, and dexamethasone
    Au, WY
    Chan, LC
    Liang, R
    Kwong, YL
    AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (06) : 471 - 473
  • [37] Reduction of Extramedullary Complications in Patients With Acute Myeloid Leukemia/Myelodysplastic Syndrome Treated With Azacitidine
    Shabanova, Iren
    Cada, Michaela
    Johnston, Donna L.
    Abbott, Lesleigh S.
    Leung, Elaine W.
    Schechter, Tal
    Dror, Yigal
    Klaassen, Robert J.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2020, 42 (03) : 170 - 174
  • [38] Clinical experience with Azacitidine in myelodysplastic syndrome and low blast count acute myeloid leukemia
    Gawliczek, A.
    Stein, W.
    Kokowski, K.
    Kiehl, M. G.
    ONKOLOGIE, 2011, 34 : 147 - 147
  • [39] MONITORING OF THE CYTOGENETIC ALTERATIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA/MYELODYSPLASTIC SYNDROME TREATED WITH AZACITIDINE
    De Gusmao, B.
    Campeny, A.
    Perez-Persona, E.
    Oiartzabal, I.
    Ardanaz, M.
    Menchaca, M.
    Mendizabal, A.
    Wong, J.
    Pereda, A.
    de Castro, J.
    HAEMATOLOGICA, 2013, 98 : 582 - 583
  • [40] Risk of therapy-related myelodysplastic syndrome/acute myeloid leukemia after childhood cancer: a population-based study
    Advani, Pragati G.
    Schonfeld, Sara J.
    Curtis, Rochelle E.
    Dores, Graca M.
    Linet, Martha S.
    Sigel, Byron S.
    Lam, Clara J. K.
    Tucker, Margaret A.
    Chanock, Stephen J.
    Morton, Lindsay M.
    LEUKEMIA, 2019, 33 (12) : 2947 - 2951
12345